Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Kristen N. Balogh | Researchclopedia

Back to researchers

Kristen N. Balogh

BioNTech (United States)ORCID

22

Works

1,149

Citations

7

h-index

6

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses CAR-T cell therapy research

Affiliations

BioNTech (United States)2020–2026

University of Virginia2015–2022

Top Works

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Patrick A. Ott,Siwen Hu‐Lieskovan,et al.

2020717 citations

Macrophage Migration Inhibitory Factor

vaccines and immunoinformatics approaches

Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer

Mark M. Awad,Ramaswamy Govindan,et al.

2022212 citations

Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses

Kristen N. Balogh,Dennis J. Templeton,et al.

2018106 citations

Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1

Asaf Poran,Julian Scherer,et al.

202046 citations

Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial

Jessica S.W. Borgers,Divya Lenkala,et al.

202534 citations

Myeloid Derived Suppressor Cells Migrate in Response to Flow and Lymphatic Endothelial Cell Interaction in the Breast Tumor Microenvironment

LaDeidra Monét Roberts,Matthew J. Perez,et al.

202217 citations

Abstract 942: The personalized vaccine, NEO-PV-01 with anti-PD1, induces neoantigen-specific de novo immune responses in patients with advanced metastatic melanoma: Association with clinical outcomes

Siwen Hu‐Lieskovan,Patrick A. Ott,et al.

20198 citations

Abstract 73: A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first-line non-squamous NSCLC: Associations with clinical outcomes

Mark M. Awad,Ramaswamy Govindan,et al.

20214 citations

Abstract 5006: Comprehensive gene expression analysis of the tumor microenvironment in patients with advanced cancer treated with a personalized neoantigen vaccine, NEO-PV-01, in combination with anti-PD1

Meghan E. Bushway,Ying S. Ting,et al.

20191 citations